Director/PDMR Shareholding
April 23 2010 - 4:00AM
UK Regulatory
TIDMLPX
RNS Number : 6633K
Lipoxen PLC
23 April 2010
+---------------------------------+---------------------------------+
| For immediate release | 23 April 2010 |
+---------------------------------+---------------------------------+
Lipoxen PLC
('Lipoxen' or 'the Company')
DIRECTOR DEALING
Lipoxen PLC (AIM: LPX), a bio-pharmaceutical company specialising in the
development of high-value differentiated biologicals, vaccines and siRNA
delivery, is pleased to announce that further to the announcement released on 1
April 2010, that the Company has raised GBP1.2 million through a non pre-emptive
issue of shares (the "Fundraising"), certain directors have acquired ordinary
shares of 0.5 pence each (the "New Ordinary Shares"). Details of the director
dealings are set out in the table below:
+--------------+----------+-----------+-----------+----------+
| Name | Date | Shares | Total | % of |
| | | acquired | interest | total |
| | | | | issued |
| | | | | share |
| | | | | capital |
+--------------+----------+-----------+-----------+----------+
| Sir Brian | 1 April | 1,071,429 | 2,262,606 | 1.32 |
| Richards | 2010 | | | |
+--------------+----------+-----------+-----------+----------+
| Scott | 1 April | 535,714 | 1,301,362 | 0.76 |
| Maguire | 2010 | | | |
+--------------+----------+-----------+-----------+----------+
| Colin Hill | 1 April | 535,714 | 1,675,420 | 0.97 |
| | 2010 | | | |
+--------------+----------+-----------+-----------+----------+
| | | | | |
+--------------+----------+-----------+-----------+----------+
- Ends -
For further information please contact:
+------------------------------------------+--------------------+
| Lipoxen plc | +44 (0)20 7389 |
| | 5015 |
+------------------------------------------+--------------------+
| M. Scott Maguire, Chief Executive | |
| Officer | |
+------------------------------------------+--------------------+
| | |
+------------------------------------------+--------------------+
| Singer Capital Markets (nominated | +44 (0)20 3205 |
| adviser) | 7500 |
+------------------------------------------+--------------------+
| Jeff Keating / Claes Spång | |
+------------------------------------------+--------------------+
| | |
+------------------------------------------+--------------------+
| Buchanan Communications | +44 (0)20 7466 |
| | 5000 |
+------------------------------------------+--------------------+
| Lisa Baderoon / Catherine Breen | |
+------------------------------------------+--------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSKMGZDVZZGGZM
Lipoxen (LSE:LPX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Lipoxen (LSE:LPX)
Historical Stock Chart
From Oct 2023 to Oct 2024